Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy

BACKGROUND/AIMS: Anti-thymocyte globulin (ATG) treatment for acute T-cell mediated rejection (TCMR) can increase the risk of cytomegalovirus (CMV) infection. We aimed to evaluate the effect of valacyclovir prophylaxis against CMV infection after ATG administration as anti-rejection therapy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Eun Jeong, Yu, Ji Hyun, Yang, Chul Woo, Chung, Byung Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406088/
https://www.ncbi.nlm.nih.gov/pubmed/29237252
http://dx.doi.org/10.3904/kjim.2017.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406088/
https://www.ncbi.nlm.nih.gov/pubmed/29237252
http://dx.doi.org/10.3904/kjim.2017.040

Ejemplares similares